Farhad Azimi
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Breast Cancer Treatment Studies 6
- Cancer Genomics and Diagnostics 4
- Oncology 6
- Cutaneous Melanoma Detection and Management 2
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 2
- Co-authors
- Richard Scolyer (1 shared paper)Marc D. Moncrieff (1 shared paper)Rajmohan Murali (1 shared paper)Stanley W. McCarthy (1 shared paper)Robyn P. M. Saw (1 shared paper)John F. Thompson (1 shared paper)Patrick J. Bryan (2 shared papers)Sanjay Kumar Warrier (7 shared papers)
- Journals
- Annals of Surgical Oncology (4 papers)Clinical Radiology (2 papers)Journal of Clinical Oncology (1 paper)Life (1 paper)PLoS ONE (1 paper)
- Partner nations
- AustraliaUnited States
In The Last Decade
Farhad Azimi
16 papers receiving 742 citations
Farhad Azimi's Hit Papers
Peers
Comparison fields: 5 of 57
- Oncology 433
- Immunology 256
- Cancer Research 91
- Pulmonary and Respiratory Medicine 124
- Molecular Biology 191
Countries citing papers authored by Farhad Azimi
This map shows the geographic impact of Farhad Azimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Azimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Azimi more than expected).
Fields of papers citing papers by Farhad Azimi
This network shows the impact of papers produced by Farhad Azimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Azimi. The network helps show where Farhad Azimi may publish in the future.
Co-authors
The 25 scholars most cited alongside Farhad Azimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma Hit paper breakdown → | 2012 | 673 |
| 2 | 2023 | 19 | |
| 3 | 2019 | 18 | |
| 4 | 1974 | 8 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 5 | |
| 8 | 1974 | 5 | |
| 9 | 1977 | 3 | |
| 10 | 2022 | 2 | |
| 11 | 2020 | 2 | |
| 12 | 1974 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2024 | 0 |
About Farhad Azimi
Farhad Azimi is a scholar working on Cancer Research, Oncology, Dermatology, Genetics and Pathology and Forensic Medicine, having authored 17 papers that have together received 752 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Cancer Genomics and Diagnostics (4 papers), Cutaneous Melanoma Detection and Management (2 papers), CAR-T cell therapy research (2 papers), Breast Lesions and Carcinomas (2 papers), Connective tissue disorders research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Oncology (433 citations), Immunology (256 citations), Cancer Research (91 citations), Pulmonary and Respiratory Medicine (124 citations) and Molecular Biology (191 citations). Farhad Azimi has collaborated with scholars based in Australia and United States. Frequent co-authors include Richard Scolyer, Marc D. Moncrieff, Rajmohan Murali, Stanley W. McCarthy, Robyn P. M. Saw, John F. Thompson, Patrick J. Bryan, Sanjay Kumar Warrier, Cindy Mak and Chu Luan Nguyen. Their work appears in journals such as Annals of Surgical Oncology, Clinical Radiology, Journal of Clinical Oncology, Life and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.